» Articles » PMID: 4131854

Serum Alpha-fetoprotein Levels in Acute Viral Hepatitis

Overview
Journal Gut
Specialty Gastroenterology
Date 1973 Dec 1
PMID 4131854
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Serum alpha-fetoprotein levels were measured serially by radioimmunoassay in 32 patients with acute viral hepatitis. With one exception, the levels were increased during the course of the illness. Raised concentrations of the protein occurred almost equally in patients with and without the hepatitis-B antigen. In the majority of patients the rise was modest but in seven levels were reached at which alpha-fetoprotein could be detected by immunodiffusion. Very high levels were more likely to occur in children. In eight patients the concentration increased as the serum glutamic pyruvic transaminase (SGPT) level, used as an index of hepatocyte damage, was returning to normal, a pattern which favoured increased synthesis of the protein during hepatocellular regeneration. In the remainder, the alpha-fetoprotein level paralleled that of SGPT, suggesting rather an acutephase reaction to liver injury.

Citing Articles

Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review.

Turshudzhyan A, Wu G J Clin Transl Hepatol. 2022; 10(1):159-163.

PMID: 35233385 PMC: 8845163. DOI: 10.14218/JCTH.2021.00176.


Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.

Hanif H, Ali M, Susheela A, Khan I, Luna-Cuadros M, Khan M World J Gastroenterol. 2022; 28(2):216-229.

PMID: 35110946 PMC: 8776528. DOI: 10.3748/wjg.v28.i2.216.


Differentiating hepatocellular carcinoma from hepatitis C using metabolite profiling.

Wei S, Suryani Y, Gowda G, Skill N, Maluccio M, Raftery D Metabolites. 2014; 2(4):701-16.

PMID: 24957758 PMC: 3901236. DOI: 10.3390/metabo2040701.


Biomarkers: evaluation of screening for and early diagnosis of hepatocellular carcinoma in Japan and china.

Song P, Gao J, Inagaki Y, Kokudo N, Hasegawa K, Sugawara Y Liver Cancer. 2013; 2(1):31-9.

PMID: 24159594 PMC: 3747538. DOI: 10.1159/000346220.


Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus.

Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A J Gastroenterol. 2010; 46(4):536-44.

PMID: 21132575 DOI: 10.1007/s00535-010-0349-7.


References
1.
Werner M . Serum protein changes during the acute phase reaction. Clin Chim Acta. 1969; 25(2):299-305. DOI: 10.1016/0009-8981(69)90272-1. View

2.
Purcell R, Holland P, Walsh J, Wong D, Morrow A, Chanock R . A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis. 1969; 120(3):383-6. DOI: 10.1093/infdis/120.3.383. View

3.
Gocke D, Howe C . Rapid detection of Australia antigen by counterimmunoelectrophoresis. J Immunol. 1970; 104(4):1031-4. View

4.
Vogel C, ANTHONY P, Mody N, Barker L . Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet. 1970; 2(7674):621-4. DOI: 10.1016/s0140-6736(70)91396-6. View

5.
Abelev G . Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res. 1971; 14:295-358. DOI: 10.1016/s0065-230x(08)60523-0. View